INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY

INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY

Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E889-E889
Hauptverfasser: Rossignol, Patrick, Dobre, Daniela, Gregory, Douglas, Massaro, Joe, Kiernan, Michael, Konstam, Marvin, Zannad, Faiez
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Drug therapy
Ethnicity
Fractions
Heart failure
Internal Medicine
Potassium
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)60890-0